Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Regenerative and engineered options for urethroplasty.

Pederzoli F, Joice G, Salonia A, Bivalacqua TJ, Sopko NA.

Nat Rev Urol. 2019 Jun 6. doi: 10.1038/s41585-019-0198-y. [Epub ahead of print] Review.

PMID:
31171866
2.

Diagnosis of urothelial carcinoma in situ using blue light cystoscopy and the utility of immunohistochemistry in blue light-positive lesions diagnosed as atypical.

Pederzoli F, Amador BM, Samarska I, Lombardo KA, Kates M, Bivalacqua TJ, Matoso A.

Hum Pathol. 2019 May 6. pii: S0046-8177(19)30083-8. doi: 10.1016/j.humpath.2019.04.018. [Epub ahead of print]

PMID:
31071342
3.

Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles.

Rigon L, Salvalaio M, Pederzoli F, Legnini E, Duskey JT, D'Avanzo F, De Filippis C, Ruozi B, Marin O, Vandelli MA, Ottonelli I, Scarpa M, Tosi G, Tomanin R.

Int J Mol Sci. 2019 Apr 24;20(8). pii: E2014. doi: 10.3390/ijms20082014.

4.

Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy.

Tosi G, Pederzoli F, Belletti D, Vandelli MA, Forni F, Duskey JT, Ruozi B.

Prog Brain Res. 2019;245:57-88. doi: 10.1016/bs.pbr.2019.03.001. Epub 2019 Apr 2. Review.

PMID:
30961872
5.

Impaired testicular signaling of vitamin A and vitamin K contributes to the aberrant composition of the extracellular matrix in idiopathic germ cell aplasia.

Alfano M, Pederzoli F, Locatelli I, Ippolito S, Longhi E, Zerbi P, Ferrari M, Brendolan A, Montorsi F, Drago D, Andolfo A, Nebuloni M, Salonia A.

Fertil Steril. 2019 Apr;111(4):687-698. doi: 10.1016/j.fertnstert.2018.12.002.

6.

Heavy cigarette smoking and alcohol consumption are associated with impaired sperm parameters in primary infertile men.

Boeri L, Capogrosso P, Ventimiglia E, Pederzoli F, Cazzaniga W, Chierigo F, Dehò F, Montanari E, Montorsi F, Salonia A.

Asian J Androl. 2019 Feb 26. doi: 10.4103/aja.aja_110_18. [Epub ahead of print]

7.

Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology.

Gupta M, Milbar N, Tema G, Pederzoli F, Chappidi M, Kates M, VandenBussche CJ, Bivalacqua TJ.

World J Urol. 2019 Jan 23. doi: 10.1007/s00345-018-02624-3. [Epub ahead of print]

PMID:
30671639
8.

High-risk human papillomavirus in semen is associated with poor sperm progressive motility and a high sperm DNA fragmentation index in infertile men.

Boeri L, Capogrosso P, Ventimiglia E, Pederzoli F, Cazzaniga W, Chierigo F, Pozzi E, Clementi M, Viganò P, Montanari E, Montorsi F, Salonia A.

Hum Reprod. 2019 Feb 1;34(2):209-217. doi: 10.1093/humrep/dey348.

PMID:
30517657
9.

The duration of infertility affects semen parameters in primary infertile men: results of a single-centre, cross-sectional study.

Boeri L, Ventimiglia E, Capogrosso P, Pecoraro A, Pederzoli F, Cazzaniga W, Pozzi E, Alfano M, Viganò P, Montanari E, Montorsi F, Salonia A.

BJU Int. 2019 May;123(5):891-898. doi: 10.1111/bju.14613. Epub 2018 Dec 4.

PMID:
30515955
10.

Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate.

Elfandy H, Armenia J, Pederzoli F, Pullman E, Pertega-Gomes N, Schultz N, Viswanathan K, Vosoughi A, Blattner M, Stopsack KH, Zadra G, Penney KL, Mosquera JM, Tyekucheva S, Mucci LA, Barbieri C, Loda M.

Mol Cancer Res. 2019 Feb;17(2):446-456. doi: 10.1158/1541-7786.MCR-18-0440. Epub 2018 Oct 17.

PMID:
30333152
11.

Undiagnosed prediabetes is highly prevalent in primary infertile men - results from a cross-sectional study.

Boeri L, Capogrosso P, Ventimiglia E, Pederzoli F, Frego N, Cazzaniga W, Chierigo F, Alfano M, Piemonti L, Viganò P, Pontillo M, Montanari E, Montorsi F, Salonia A.

BJU Int. 2019 Jun;123(6):1070-1077. doi: 10.1111/bju.14558. Epub 2018 Oct 16.

12.

Clinical Profile of Young Patients with Erectile Dysfunction: Preliminary Findings of a Real-life Cross-sectional Study.

Pozzi E, Capogrosso P, Chierigo F, Pederzoli F, Ventimiglia E, Boeri L, Frego N, Moretti D, Dehò F, Montorsi F, Salonia A.

Eur Urol Focus. 2018 Oct 10. pii: S2405-4569(18)30296-7. doi: 10.1016/j.euf.2018.10.003. [Epub ahead of print]

PMID:
30316826
13.

Multiple PDE5Is use as a marker of decreased overall men's health: A real-life study.

Oreggia D, Ventimiglia E, Capogrosso P, Boeri L, Cazzaniga W, Pederzoli F, Chierigo F, Dehò F, Montorsi F, Salonia A.

PLoS One. 2018 Aug 10;13(8):e0201601. doi: 10.1371/journal.pone.0201601. eCollection 2018.

14.

High Blood Pressure Is a Highly Prevalent but Unrecognised Condition in Primary Infertile Men: Results of a Cross-sectional Study.

Cazzaniga W, Capogrosso P, Ventimiglia E, Pederzoli F, Boeri L, Frego N, Abbate C, Alfano M, Viganò P, Montorsi F, Salonia A.

Eur Urol Focus. 2018 Aug 3. pii: S2405-4569(18)30214-1. doi: 10.1016/j.euf.2018.07.030. [Epub ahead of print]

PMID:
30082228
15.

Unrecognized Prediabetes Is Highly Prevalent in Men With Erectile Dysfunction-Results From a Cross-Sectional Study.

Boeri L, Capogrosso P, Pederzoli F, Ventimiglia E, Frego N, Chierigo F, Montanari E, Montorsi F, Salonia A.

J Sex Med. 2018 Aug;15(8):1117-1124. doi: 10.1016/j.jsxm.2018.06.009.

PMID:
30078463
16.

The role of neutrophil-to-lymphocyte ratio in men with erectile dysfunction-preliminary findings of a real-life cross-sectional study.

Ventimiglia E, Cazzaniga W, Pederzoli F, Frego N, Chierigo F, Capogrosso P, Boeri L, Dehò F, Abbate C, Moretti D, Piemonti L, Montorsi F, Salonia A.

Andrology. 2018 Jul;6(4):559-563. doi: 10.1111/andr.12489. Epub 2018 Apr 2.

PMID:
29611369
17.

Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain.

Belletti D, Grabrucker AM, Pederzoli F, Menrath I, Vandelli MA, Tosi G, Duskey TJ, Forni F, Ruozi B.

Int J Pharm. 2018 May 30;543(1-2):300-310. doi: 10.1016/j.ijpharm.2018.03.061. Epub 2018 Mar 30.

PMID:
29608954
18.

Age at First Presentation for Erectile Dysfunction: Analysis of Changes over a 12-yr Period.

Capogrosso P, Ventimiglia E, Boeri L, Cazzaniga W, Chierigo F, Pederzoli F, Frego N, Abbate C, Dehò F, Montorsi F, Salonia A.

Eur Urol Focus. 2018 Mar 2. pii: S2405-4569(18)30068-3. doi: 10.1016/j.euf.2018.02.006. [Epub ahead of print]

PMID:
29506875
19.

Surgical Factors Associated With Male and Female Sexual Dysfunction After Radical Cystectomy: What Do We Know and How Can We Improve Outcomes?

Pederzoli F, Campbell JD, Matsui H, Sopko NA, Bivalacqua TJ.

Sex Med Rev. 2018 Jul;6(3):469-481. doi: 10.1016/j.sxmr.2017.11.003. Epub 2018 Jan 19. Review.

PMID:
29371143
20.

Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles.

Pederzoli F, Tosi G, Genovese F, Belletti D, Vandelli MA, Ballestrazzi A, Forni F, Ruozi B.

Nanomedicine (Lond). 2018 Feb;13(4):407-422. doi: 10.2217/nnm-2017-0250. Epub 2018 Jan 18.

PMID:
29345202
21.

Anti-Mullerian Hormone-to-Testosterone Ratio is Predictive of Positive Sperm Retrieval in Men with Idiopathic Non-Obstructive Azoospermia.

Alfano M, Ventimiglia E, Locatelli I, Capogrosso P, Cazzaniga W, Pederzoli F, Frego N, Matloob R, Saccà A, Pagliardini L, Viganò P, Zerbi P, Nebuloni M, Pontillo M, Montorsi F, Salonia A.

Sci Rep. 2017 Dec 15;7(1):17638. doi: 10.1038/s41598-017-17420-z.

22.

Does Calculated Free Testosterone Overcome Total Testosterone in Protecting From Sexual Symptom Impairment? Findings of a Cross-Sectional Study.

Boeri L, Capogrosso P, Ventimiglia E, Cazzaniga W, Pederzoli F, Moretti D, Dehò F, Montanari E, Montorsi F, Salonia A.

J Sex Med. 2017 Dec;14(12):1549-1557. doi: 10.1016/j.jsxm.2017.10.070.

PMID:
29198510
23.

Long-term penile morphometric alterations in patients treated with robot-assisted versus open radical prostatectomy.

Capogrosso P, Ventimiglia E, Cazzaniga W, Stabile A, Pederzoli F, Boeri L, Gandaglia G, Dehò F, Briganti A, Montorsi F, Salonia A.

Andrology. 2018 Jan;6(1):136-141. doi: 10.1111/andr.12446. Epub 2017 Dec 1.

24.

Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer.

Milbar N, Kates M, Chappidi MR, Pederzoli F, Yoshida T, Sankin A, Pierorazio PM, Schoenberg MP, Bivalacqua TJ.

Bladder Cancer. 2017 Oct 27;3(4):293-303. doi: 10.3233/BLC-170126.

25.

Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders.

Duskey JT, Belletti D, Pederzoli F, Vandelli MA, Forni F, Ruozi B, Tosi G.

Int Rev Neurobiol. 2017;137:1-28. doi: 10.1016/bs.irn.2017.08.006. Epub 2017 Oct 16. Review.

PMID:
29132540
26.

Clinically Meaningful Improvements in LUTS/BPH Severity in Men Treated with Silodosin Plus Hexanic Extract of Serenoa Repens or Silodosin Alone.

Boeri L, Capogrosso P, Ventimiglia E, Cazzaniga W, Pederzoli F, Moretti D, Dehò F, Montanari E, Montorsi F, Salonia A.

Sci Rep. 2017 Nov 9;7(1):15179. doi: 10.1038/s41598-017-15435-0.

27.

Corrigendum to: EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION (International Journal of Pharmaceutics. 511 (1) (2016) 331-340).

Belletti D, Grabrucker AM, Pederzoli F, Menrath I, Cappello V, Vandelli MA, Forni F, Tosi G, Ruozi B.

Int J Pharm. 2017 Nov 25;533(1):321. doi: 10.1016/j.ijpharm.2017.10.019. No abstract available.

PMID:
29056147
28.

Depressive Symptoms and Low Sexual Desire after Radical Prostatectomy: Early and Long-Term Outcomes in a Real-Life Setting.

Boeri L, Capogrosso P, Ventimiglia E, Cazzaniga W, Pederzoli F, Gandaglia G, Finocchio N, Dehò F, Briganti A, Montanari E, Montorsi F, Salonia A.

J Urol. 2018 Feb;199(2):474-480. doi: 10.1016/j.juro.2017.08.104. Epub 2017 Sep 1.

PMID:
28867561
29.

Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach.

Belletti D, Riva G, Luppi M, Tosi G, Forni F, Vandelli MA, Ruozi B, Pederzoli F.

Eur J Pharm Sci. 2017 Sep 30;107:230-239. doi: 10.1016/j.ejps.2017.07.020. Epub 2017 Jul 18.

PMID:
28728978
30.

Analysis of Hospital Readmissions After Prosthetic Urologic Surgery in the United States: Nationally Representative Estimates of Causes, Costs, and Predictive Factors.

Pederzoli F, Chappidi MR, Collica S, Kates M, Joice GA, Sopko NA, Montorsi F, Salonia A, Bivalacqua TJ.

J Sex Med. 2017 Aug;14(8):1059-1065. doi: 10.1016/j.jsxm.2017.06.003. Epub 2017 Jul 12.

PMID:
28709874
31.

Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates.

Barbara R, Belletti D, Pederzoli F, Masoni M, Keller J, Ballestrazzi A, Vandelli MA, Tosi G, Grabrucker AM.

Int J Pharm. 2017 Jun 30;526(1-2):413-424. doi: 10.1016/j.ijpharm.2017.05.015. Epub 2017 May 8.

PMID:
28495580
32.

Primary, secondary and compensated hypogonadism: a novel risk stratification for infertile men.

Ventimiglia E, Ippolito S, Capogrosso P, Pederzoli F, Cazzaniga W, Boeri L, Cavarretta I, Alfano M, Viganò P, Montorsi F, Salonia A.

Andrology. 2017 May;5(3):505-510. doi: 10.1111/andr.12335.

33.

Protein corona and nanoparticles: how can we investigate on?

Pederzoli F, Tosi G, Vandelli MA, Belletti D, Forni F, Ruozi B.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Nov;9(6). doi: 10.1002/wnan.1467. Epub 2017 Mar 15. Review.

PMID:
28296346
34.

Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system.

Ruozi B, Veratti P, Vandelli MA, Tombesi A, Tonelli M, Forni F, Pederzoli F, Belletti D, Tosi G.

Int J Pharm. 2017 Feb 25;518(1-2):281-288. doi: 10.1016/j.ijpharm.2016.12.038. Epub 2016 Dec 23.

PMID:
28017769
35.

Sexual functioning mirrors overall men's health status, even irrespective of cardiovascular risk factors.

Capogrosso P, Ventimiglia E, Boeri L, Capitanio U, Gandaglia G, Dehò F, Pederzoli F, Cazzaniga W, Scano R, Montorsi F, Salonia A.

Andrology. 2017 Jan;5(1):63-69. doi: 10.1111/andr.12299.

36.

Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin.

Belletti D, Pederzoli F, Forni F, Vandelli MA, Tosi G, Ruozi B.

Expert Opin Drug Deliv. 2017 Jul;14(7):825-840. doi: 10.1080/17425247.2017.1243528. Epub 2016 Oct 21. Review.

PMID:
27690258
37.

Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain.

Ruozi B, Belletti D, Pederzoli F, Forni F, Vandelli MA, Tosi G.

CNS Neurol Disord Drug Targets. 2016;15(9):1079-1091. Review.

PMID:
27633786
38.

Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system?

Tosi G, Belletti D, Pederzoli F, Ruozi B.

Expert Opin Drug Deliv. 2016 Oct;13(10):1341-3. doi: 10.1080/17425247.2016.1224848. Epub 2016 Aug 26. No abstract available.

PMID:
27560784
39.

EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION.

Belletti D, Grabrucker AM, Pederzoli F, Menrath I, Cappello V, Vandelli MA, Forni F, Tosi G, Ruozi B.

Int J Pharm. 2016 Sep 10;511(1):331-340. doi: 10.1016/j.ijpharm.2016.07.022. Epub 2016 Jul 12. Erratum in: Int J Pharm. 2017 Nov 25;533(1):321.

PMID:
27418565
40.

When to Perform Karyotype Analysis in Infertile Men? Validation of the European Association of Urology Guidelines with the Proposal of a New Predictive Model.

Ventimiglia E, Capogrosso P, Boeri L, Pederzoli F, Cazzaniga W, Scano R, Ippolito S, Fossati N, Alfano M, Montorsi F, Salonia A.

Eur Urol. 2016 Dec;70(6):920-923. doi: 10.1016/j.eururo.2016.06.015. Epub 2016 Jun 21.

PMID:
27343001
41.

Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders.

Salvalaio M, Rigon L, Belletti D, D'Avanzo F, Pederzoli F, Ruozi B, Marin O, Vandelli MA, Forni F, Scarpa M, Tomanin R, Tosi G.

PLoS One. 2016 May 26;11(5):e0156452. doi: 10.1371/journal.pone.0156452. eCollection 2016.

42.

Nanoparticle transport across the blood brain barrier.

Grabrucker AM, Ruozi B, Belletti D, Pederzoli F, Forni F, Vandelli MA, Tosi G.

Tissue Barriers. 2016 Feb 25;4(1):e1153568. doi: 10.1080/21688370.2016.1153568. eCollection 2016 Jan-Mar. Review.

43.

PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity.

Belletti D, Tosi G, Forni F, Lagreca I, Barozzi P, Pederzoli F, Vandelli MA, Riva G, Luppi M, Ruozi B.

Eur J Pharm Biopharm. 2016 Feb;99:7-17. doi: 10.1016/j.ejpb.2015.11.007. Epub 2015 Nov 25.

PMID:
26625717
44.

Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots.

Pederzoli F, Ruozi B, Pracucci E, Signore G, Zapparoli M, Forni F, Vandelli MA, Ratto G, Tosi G.

Nanotechnology. 2016 Jan 8;27(1):015704. doi: 10.1088/0957-4484/27/1/015704. Epub 2015 Nov 24.

PMID:
26597894
45.

Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments.

Tosi G, Vilella A, Veratti P, Belletti D, Pederzoli F, Ruozi B, Vandelli MA, Zoli M, Forni F.

Mol Pharm. 2015 Oct 5;12(10):3672-84. doi: 10.1021/acs.molpharmaceut.5b00446. Epub 2015 Sep 1.

PMID:
26312414
46.

Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles.

Vilella A, Ruozi B, Belletti D, Pederzoli F, Galliani M, Semeghini V, Forni F, Zoli M, Vandelli MA, Tosi G.

Pharmaceutics. 2015 Jun 19;7(2):74-89. doi: 10.3390/pharmaceutics7020074. Review.

47.

Nanotechnology and Alzheimer's disease: what has been done and what to do.

Ruozi B, Belletti D, Pederzoli F, Veratti P, Forni F, Vandelli MA, Tosi G.

Curr Med Chem. 2014;21(36):4169-85. Review.

PMID:
25039777
48.

Clinical severity of ischemic stroke and neural damage biomarkers in the acute setting: the STROke MArkers (STROMA) study.

Barbieri A, Giuliani E, Carone C, Pederzoli F, Mascheroni G, Greco G, Stucchi C, Genedani S.

Minerva Anestesiol. 2013 Jul;79(7):750-7. Epub 2013 Mar 19.

PMID:
23511364
49.

Microvesicle and tunneling nanotube mediated intercellular transfer of g-protein coupled receptors in cell cultures.

Guescini M, Leo G, Genedani S, Carone C, Pederzoli F, Ciruela F, Guidolin D, Stocchi V, Mantuano M, Borroto-Escuela DO, Fuxe K, Agnati LF.

Exp Cell Res. 2012 Mar 10;318(5):603-13. doi: 10.1016/j.yexcr.2012.01.005. Epub 2012 Jan 11.

PMID:
22266577
50.

Effect of 6 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients.

Coppa GV, Buzzega D, Zampini L, Maccari F, Galeazzi T, Pederzoli F, Gabrielli O, Volpi N.

Glycobiology. 2010 Oct;20(10):1259-73. doi: 10.1093/glycob/cwq088. Epub 2010 Jun 9.

PMID:
20538645

Supplemental Content

Loading ...
Support Center